The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals

References

• Bernstein W B, Little R F, Wilson W H, Yarchon R. Acquiredimmunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol 2006; 84: 3–11
   Web of Science ®Google Scholar
• Boivin G. Diagnosis of herpesvirus infections of the central nervous system. HERPES 2004; 11: 48A–56A, (Suppl 2)
   Google Scholar
• Brink N S, Sharvell Y, Howard M R, Fox J D, Harrison M J, Miller R F. Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. J Neurol Neurosurg Psychiatry 1998; 65: 191–195
   PubMedGoogle Scholar
• Broccolo F, Iuliano R, Careddu A M, Trovato R, Lico S, Blanc P L, Mazzotta F, Ceccherini-Nelli L. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol 2000; 44: 137–143
   PubMedGoogle Scholar
• Brodt H R, Kamps B S, Gute P, Knupp B, Staszewski S, Helm E B. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11: 1731–1738
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1–19
   Google Scholar
• Chaudhuri A, Kennedy P G. Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002; 78: 575–583
   PubMed Web of Science ®Google Scholar
• Corti M, Villafañe F, Trione N, Schtirbu R, Yampolsky C, Narbaitz M. Primary central nervous system lymphomas in AIDS patients. Enferm Infect Microbiol Clin 2004; 22: 332–336
   Google Scholar
• d'Arminio M A, Duca P G, Vago L, Grassi M P, Moroni M. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 2000; 54: 1856–1859
   Google Scholar
• Deayton J R, Griffiths P D. When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease?. Curr Opin Infect Dis 2000; 13: 637–641
   Google Scholar
• DeBiasi R L, Tyler K L. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004; 17: 903–925
   PubMed Web of Science ®Google Scholar
• Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. HERPES 2004; 11: 105A–111A
   PubMedGoogle Scholar
• Eza D, Cerrillo G, Moore D A, Castro C, Ticona E, Morales D, Cabanillas J, Barrantes F, Alfaro A, Benavides A, Rafael A, Valladares G, Arevalo F, Evans C A, Gilman R H. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract 2006; 202: 767–775
   PubMed Web of Science ®Google Scholar
• Fica A, Pérez C, Reyes P O, Gallardo S P, Calvo X P, Salinas A. Herpetic encephalitis. Case series of 15 patients confirmed by polymerase chain reaction. Rev Chil Infect 2005; 22: 38–46
   Google Scholar
• French M A, Price P, Stone S F. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615–1627
   PubMed Web of Science ®Google Scholar
• Gerna G, Piccinini G, Genini E, Percivalle E, Zavattoni M, Lilleri D, Testa L, Comolli G, Maserati R, Baldanti F, Maccario R, Monforte A D, Revello M G. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. J Acquir Immune Defic Syndr 2001; 28: 320–331
   PubMed Web of Science ®Google Scholar
• Glaser C A, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen C K, Anderson L J. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis 2003; 36: 731–742, California Encephalitis Project, 1998–2000
   PubMed Web of Science ®Google Scholar
• Griffiths P. Cytomegalovirus Infection of the Central Nervous System. HERPES 2004; 11: 95A–104A, (Suppl 2)
   Google Scholar
• Keane N M, Price P, Lee S, Almeida C A, Stone S F, James I, French M A. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Med 2004; 5: 407–414
   Google Scholar
• Kennedy P G. Viral encephalitis. J Neurol 2005; 252: 268–272
   PubMed Web of Science ®Google Scholar
• Kourí V, Resik S, Tenorio A, Suárez C, García S. Meningoencefalitis por virus de la familia herpesviridae en Cuba. Período 1996–1998. Rev Argent Microbiol 2000; 32: 77–82
   Google Scholar
• Lee T C, Tsai C P, Yuan C L, Wei C Y, Tsao W L, Lee R J, Cheih S Y, Huang I T, Chen K T. Encephalitis in Taiwan: a prospective hospital-based study. Jpn J Infect Dis 2003; 56: 193–199
   PubMedGoogle Scholar
• Mamidi A, De Simone J A, Pomerantz R J. Central nervous system infections in individuals with HIV-1 infection. J NeuroVirol 2002; 8: 158–167
   PubMed Web of Science ®Google Scholar
• Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000; 69: 376–380
   PubMed Web of Science ®Google Scholar
• McGrath N, Anderson N E, Croxson M C, Powell K F. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997; 63: 321–326
   PubMed Web of Science ®Google Scholar
• Michaels J, the Adult Spectrum of Disease Cohort. Opportunistic incidence rates from the Tulane/ adult spectrum of disease cohort, 1994–8. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, February, 1–5, 1998
   Google Scholar
• Minjolle S, Arvieux C, Gautier A L, Jusselin I, Thomas R, Michelet C, Colimon R. Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings. J Clin Virol 2002; 25: S59–S70, (Suppl 1)
   Google Scholar
• Neuenburg J K, Brodt H R, Herndier B G, Bickel M, Bacchetti P, Price R W, Grant R M, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 171–177
   PubMed Web of Science ®Google Scholar
• Palella F J, Jr, Delaney K M, Moorman A C, Loveless M O, Fuhrer J, Satten G A, Aschman D J, Holmberg S D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853–860
   PubMed Web of Science ®Google Scholar
• Pérez J, Pérez D, Gonzalez I, Diaz Jidy M, Orta M, Aragonés C, Joanes J, Santín M, Lantero M I, Torres R, González A, Álvarez A. Approaches to the management of HIV/AIDS in Cuba. 2004, WHO Library Cataloguing-in-Publication Data
   Google Scholar
• Quereda C, Corral I, Laguna F, Valencia M E, Tenorio A, Echeverria J E, Navas E, Martín-Dávila P, Moreno A, Moreno V, Gonzalez-Lahoz J M, Arribas J R, Guerrero A. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol 2000; 38: 3061–3067
   Google Scholar
• Read S J, Kurt J B. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol 1999; 37: 1352–1355
   PubMed Web of Science ®Google Scholar
• Herpesvirus infections in the immunocompromised host with HIV—update. Recommendations from the IHMF Management Strategies Workshop and 4th Annual Meeting, A Sivayathorn, R J Whitley. 1996
   Google Scholar
• Skoldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl 1996; 100: 8–13
   PubMedGoogle Scholar
• Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy P GE. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005; 12: 331–343
   PubMed Web of Science ®Google Scholar
• Tang Y W, Espy M J, Persing D H, Smith T F. Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J Clin Microbiol 1997; 35: 2869–2872
   PubMedGoogle Scholar
• Tenorio A, Echevarría J E, Casas I, Echevarría J M, Tabarés E. Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J Virol Methods 1993; 44: 261–269
   PubMedGoogle Scholar
• Toledo P V, Pellegrino L N, Cunha C A. Varicella-zoster virus encephalitis in an AIDS patient. Braz J Infect Dis 2004; 8: 255–258
   Google Scholar
• Tselis A, Lavi E. Cytomegalovirus infection of the adult nervous system. Infectious diseases of the nervous system, L E Davis, P GE Kennedy. Butterworth-Heinemann, Oxford 2000; 109–138
   Google Scholar
• Vago L, Nebuloni M, Sala E, Cinque P, Bonetto S, Isella A, Ottoni L, Crociati A, Costanzi G. Coinfection of the central nervous system by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: autopsy study on 82 cases by immunohistochemistry and polymerase chain reaction. Acta Neuropathol 1996; 92: 404–408
   Google Scholar
• Weinberg A, Bloch K C, Li S, Tang Y W, Palmer M, Tyler K L. Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis 2005; 191: 234–237
   PubMed Web of Science ®Google Scholar
• Yazdanpanah Y, Chene G, Losina E, Goldie S J, Merchadou L D, Alfandari S, Seage G R, 3rd, Sullivan L, Marimoutou C, Paltiel A D, Salamon R, Mouton Y, Freedberg K A. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol 2001; 30: 864–871
   PubMed Web of Science ®Google Scholar
• Zelman I B, Mossakowski M J. Opportunistic infections of the central nervous system in the course of acquired immune deficiency syndrome (AIDS). Morphological analysis of 172 cases. Folia Neuropathol 1998; 36: 129–144
   Google Scholar